The semiconductor design firm Synopsys is confronting significant headwinds as regulatory scrutiny and investor lawsuits converge. Mere months after finalizing its multi-billion dollar acquisition of Ansys, the company now faces public criticism from the U.S. Federal Trade Commission and a series of class action filings alleging securities fraud.
Investor Lawsuits Allege Misrepresentation
Several law firms initiated securities litigation against Synopsys on Thursday, contending the company misled shareholders about business risks and customer conditions between December 2024 and September 2025. These legal actions stem from a disappointing third-quarter earnings report released on September 9, 2025, where Synopsys fell substantially short of its own projections.
The company’s Intellectual Property segment performed particularly poorly, attributed to newly imposed export restrictions affecting China, difficulties with a major semiconductor foundry client, and internal strategic missteps. Market reaction was severe, with share prices plunging approximately 35% the following trading session.
Should investors sell immediately? Or is it worth buying Synopsys?
FTC Raises Compliance Concerns
Compounding these challenges, the FTC publicly expressed dissatisfaction with how Synopsys and Ansys are implementing requirements related to their $35 billion merger. Although the transaction received regulatory approval in July 2025, it was conditional upon the divestiture of specific software assets to Keysight Technologies to maintain competitive markets. The regulatory body now suggests the companies may not be fulfilling these obligations according to the agreed terms, creating uncertainty about potential additional integration obstacles.
December Earnings Report Looms Large
Attention now turns to December 10, 2025, when Synopsys will disclose fourth-quarter and full-year 2025 financial results. This upcoming report represents a critical test for management, who must demonstrate control over operational issues, provide updates on the Ansys integration progress, and show evidence of business stabilization. With investor confidence shaken by recent developments, market participants will scrutinize every detail of this forthcoming announcement.
Ad
Synopsys Stock: Buy or Sell?! New Synopsys Analysis from November 7 delivers the answer:
The latest Synopsys figures speak for themselves: Urgent action needed for Synopsys investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 7.
Synopsys: Buy or sell? Read more here...
